Nautilus Biotechnology, Inc. (NAUT) earnings date
Feb 24, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 28 days, typically, give or take 14 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Oct 26, 2026 | after close | 26 | 8-K |
| Q2 FY2026 | Mon, Jul 27, 2026 | after close | 27 | 8-K |
| Q1 FY2026 | Mon, Apr 27, 2026 | after close | 27 | 8-K |
| Q4 FY2025 | Wed, Feb 25, 2026 | after close | 56 | 8-K |
| Q3 FY2025 | Mon, Oct 27, 2025 | after close | 27 | 8-K |
| Q2 FY2025 | Wed, Jul 30, 2025 | after close | 30 | 8-K |
| Q1 FY2025 | Mon, Apr 28, 2025 | after close | 28 | 8-K |
| Q4 FY2024 | Wed, Feb 26, 2025 | after close | 57 | 8-K |
What they guided beta
| Q3 FY2026 | "Webcast and Conference Call Information Nautilus will host a conference call to discuss the third quarter 2026 financial results, business developments and outlook before market open on Tuesday, October 27, 2026, at 5:30 AM Pacific Time / 8:30 AM Eastern Time." exhibit |
| Q2 FY2026 | "We have selected and are advancing our first oncology proteoform, AKT1, with expected Early Access availability in late 2026." exhibit |
| Q2 FY2026 | "Launch expected in early 2027 for pre-orders and anticipated instrument shipment beginning in mid 2027, timed with the Proteoforms Assay consumable kits listed below." exhibit |
| Q2 FY2026 | "AKT1 Proteoforms Assay: Expected to enter the Iterative Mapping Early Access Program in late 2026, with general availability of consumable kits expected in mid 2027." exhibit |
| Q2 FY2026 | "Second oncology proteoforms assay with expected general availability of consumable kits in mid 2027" exhibit |
| Q2 FY2026 | "Webcast and Conference Call Information Nautilus will host a conference call to discuss the second quarter 2026 financial results, business developments and outlook before market open on Tuesday, July 28, 2026, at 5:30 AM Pacific Time / 8:30 AM Eastern Time." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NAUT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NAUT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/NAUT/"><img src="https://veritasdata.dev/embed/NAUT.svg" alt="NAUT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/NAUT/)
Script
<script async src="https://veritasdata.dev/embed/NAUT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NAUT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.